The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...
Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorablesafety ...
The Galien Foundation, a global institution committed to recognizing collaborative scientific and medical innovations that advance patient care, celebrated the inaugural Prix Galien Bridges Awards on ...
DelveInsight's Acute on Chronic Liver Failure Market Insights report includes a comprehensive understanding of current treatment practices, acute on chronic liver failure emerging drugs, market share ...
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cycles ...
Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall response rate(ORR) in this subgroup of patients; 80% ORR ...
News9Live on MSN
1 lakh crore national RDI fund to unlock high-impact innovation
The centre has opened up innovative financing to industries through a layered RDI fund. The fund is aimed to accelerate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback